1 / 21

Education in Palliative and End-of-life Care - Oncology

The. EPEC-O. TM. Education in Palliative and End-of-life Care - Oncology. Project. The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong Foundation.

ianthe
Download Presentation

Education in Palliative and End-of-life Care - Oncology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The EPEC-O TM Education in Palliative and End-of-life Care - Oncology Project The EPEC-O Curriculum is produced by the EPECTM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong Foundation.

  2. EPEC – Oncology Education in Palliative and End-of-life Care – Oncology Module 3j Symptoms – Dyspnea

  3. Dyspnea • Definition: uncomfortable awareness of breathing Dudgeon DJ. J Pain Symptom Manage, 1998.

  4. Anxiety Airway obstruction Bronchospasm Hypoxemia Pleural effusion Pneumonia Pulmonary edema Pulmonary embolism Thick secretions Anemia Metabolic Family / financial / legal / spiritual / practical issues Causes

  5. Dyspnea • Impact: one of most frightening symptoms

  6. Prevalence / prognosis • Prevalence 21 – 90 % in patients with life-threatening illness • Prognosis < 6 months when no underlying treatment for malignancy

  7. Key points • Pathophysiology • Assessment • Management

  8. Pathophysiology . . . • Respiratory center (medulla and pons) • Coordinates diaphragm, intercostal and accessory muscles of respiration • Sensory input from • Chemoreceptors (pO2, pCO2) • Mechanoreceptors (stretch, irritation)

  9. . . . Pathophysiology • Work of breathing • Resistance (COPD, obstruction) • Weakened muscles (cachexia) • Chemical • Hypoxemia, hypercarbia (small role in cancer) • Neuromechanical dissociation • Mismatch between brain and sensory feedback

  10. Assessment . . . • May be described as • Shortness of breath • A smothering feeling • Inability to get enough air • Suffocation

  11. . . . Assessment • The only reliable measure is patient self-report • Respiratory rate, pO2, blood gas determinations DO NOT correlate with the feeling of breathlessness

  12. Management • Treat the underlying cause, eg. • Thoracentesis • Bronchial Stents • Symptomatic management • Oxygen • Opioids • Anxiolytics • Non-pharmacological interventions

  13. Opioids • Relief not related to respiratory rate • No ethical or professional barriers • Small doses • Central and peripheral action Bruera E, et al. Ann Int Med, 1993. Mazzocato C, et al. Ann Oncol, 1999. Allard P, et al. J Pain Symptom Manage, 1999.

  14. Anxiolytics • Safe in combination with opioids • Lorazepam • 0.5 – 2 mg PO q 1 h PRN until settled • then dose routinely q 4 – 6 h to keep settled

  15. Oxygen • Pulse oximetry not helpful • Potent symbol of medical care • Expensive • Fan may do just as well Bruera E, et al. Lancet, 1993.

  16. Non-pharmacological interventions . . . • Reassure, work to manage anxiety • Behavioral approaches, eg, relaxation, distraction, hypnosis • Limit the number of people in the room • Open window Bredin J, et al. BMJ, 1999.

  17. . . . Non-pharmacological interventions . . . • Eliminate environmental irritants • Keep line of sight clear to outside • Reduce the room temperature • Avoid chilling the patient

  18. . . . Non-pharmacological interventions • Introduce humidity • Reposition • Elevate the head of the bed • Move patient to one side or other • Educate, support the family

  19. Specific situations . . . • Refractory dyspnea • Dyspnea at the end of life • Bronchospasm

  20. . . . Specific situations • Thick secretions • Pleural effusion • Anemia • Airway obstruction

  21. Summary Use comprehensive assessment and pathophysiology-based therapy to treat the cause and improve the cancer experience

More Related